When people live for many years, even decades, following a cancer diagnosis, it is hard to conduct trials large enough to find any kind of survival benefit to screening or early treatment.
Only giant clinical trials measuring hard outcomes like heart attacks, strokes and deaths can tell doctors whether a heart drug's benefits outweigh its risks.